GGrantIndex
← Leaderboards

William B Parker

Southern Research Institute

$3,366,132
Attributed
$3,366,132
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.8M · FY200513
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$12,723,851 · 7

By mechanism

U19$4,851,622 · 2
P01$4,734,498 · 2
R01$3,129,231 · 1
R13$8,500 · 2

Top collaborators

No co-investigators on record.

Most similar at Southern Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Drug Design /Synthesis /Production

Research focus

Drug Design /Synthesis /ProductionPurine AnalogPurine NucleosidesAntineoplasticsProdrugsNucleoside AnalogCooperative StudyPurine Nucleoside PhosphorylaseCytotoxicityEnzyme MechanismNeoplasm /Cancer PharmacologyMycobacterium TuberculosisAntitubercular AgentsEnzyme SubstrateDrug Screening /EvaluationDrug MetabolismAdenosineNew AgentsAnalogAntiviral AgentsNucleosidesBiologicalComplementLead

Grant awards (21)

2013 Nucleosides, Nucleotides, and Oligonucleotides Gordon Research Conference$5,000
R13 · FY2013 · AI · contact PI
2011 Nucleosides, Nucleotides, and Oligonucleotides GRC$3,500
R13 · FY2011 · CA · contact PI
Purine Analog Anti-Mycobacterial Drug Development$452,871
R01 · FY2009 · AI · contact PI
Purine Analog Anti-Mycobacterial Drug Development$453,972
R01 · FY2008 · AI · contact PI
Purine Analog Anti-Mycobacterial Drug Development$463,721
R01 · FY2007 · AI · contact PI
Purine Analog Anti-Mycobacterial Drug Development$478,491
R01 · FY2006 · AI · contact PI
Development of New Antitumor Agents$2,285,466
P01 · FY2005 · CA
Purine Analog Anti-Mycobacterial Drug Development$491,096
R01 · FY2005 · AI
Development of New Antitumor Agents$2,220,631
P01 · FY2004 · CA
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP$1,094,836
U19 · FY2004 · CA
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP$1,070,294
U19 · FY2003 · CA
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP$1,031,218
U19 · FY2002 · CA
MECHANISM OF ACTION OF NUCLEOSIDE ANALOGS$228,401
P01 · FY2002 · CA
PURINE NUCLEOSIDE ANALOGS ACTIVATED BY E COLI PNP$0
U19 · FY2002 · CA
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP$1,006,199
U19 · FY2001 · CA
PURINE ANALOG ANTIMYCOBACTERIAL DRUG DEVELOPMENT$400,369
R01 · FY2001 · AI
MECHANISM OF ACTION OF NUCLEOSIDE ANALOGS$0
P01 · FY2001 · CA
PURINE NUCLEOSIDE ANALOGS ACTIVATED BY E COLI PNP$0
U19 · FY2001 · CA
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP$649,075
U19 · FY2000 · CA
PURINE ANALOG ANTIMYCOBACTERIAL DRUG DEVELOPMENT$388,711
R01 · FY2000 · AI
PURINE NUCLEOSIDE ANALOGS ACTIVATED BY E COLI PNP$0
U19 · FY2000 · CA